VeriMompanax ginseng root extract은 임신 중 안전한가요?
Panax ginseng root extract is not listed on EU Annex II or III (no EU ban/restriction found) and there is no harmonised CLP H360/H361 entry for the extract, but peer-reviewed and regulatory literature show mixed reproductive/developmental findings: the CIR safety review (industry/CIR dossier) reports no adverse effects in some in‑vivo reproductive studies at certain doses but notes embryo morphological score reductions for isolated ginsenosides in embryo culture and other animal studies describing altered reproductive/endocrine outcomes after prenatal exposure. A controlled human evidence base for topical cosmetic use in pregnancy is limited. Because of demonstrated in‑vivo/in‑vitro developmental or endocrine effects in some studies, I score hazard as 2 (suspected). Mechanistically, ginsenosides (major constituents) show in vitro endocrine/phytoestrogenic activity and some developmental effects in embryo assays, so m=2. Exposure from topical cosmetic use is expected to be low but measurable (CIR lists typical cosmetic concentrations often <<1%), so e=1.
임신 중 panax ginseng root extract 대체 안전 성분 | VeriMom
Related ingredients
Frequently asked questions
- panax ginseng root extract은 임신 중 안전한가요?
- Panax ginseng root extract is not listed on EU Annex II or III (no EU ban/restriction found) and there is no harmonised CLP H360/H361 entry for the extract, but peer-reviewed and regulatory literature show mixed reproductive/developmental findings: the CIR safety review (industry/CIR dossier) reports no adverse effects in some in‑vivo reproductive studies at certain doses but notes embryo morphological score reductions for isolated ginsenosides in embryo culture and other animal studies describing altered reproductive/endocrine outcomes after prenatal exposure. A controlled human evidence base for topical cosmetic use in pregnancy is limited. Because of demonstrated in‑vivo/in‑vitro developmental or endocrine effects in some studies, I score hazard as 2 (suspected). Mechanistically, ginsenosides (major constituents) show in vitro endocrine/phytoestrogenic activity and some developmental effects in embryo assays, so m=2. Exposure from topical cosmetic use is expected to be low but measurable (CIR lists typical cosmetic concentrations often <<1%), so e=1.
- panax ginseng root extract은 모유 수유 중 안전한가요?
- No regulatory ban or harmonised CLP for the extract; however animal and in vitro data show reproductive/endocrine activity (see CIR and PubMed studies). Transfer of specific ginsenosides into milk is not well-documented for topical cosmetic exposure; nonetheless, because there is evidence of endocrine activity after prenatal exposure in animals, the hazard is scored as 2. Mechanistic concerns (phytoestrogenic/endocrine-active ginsenosides) justify m=2. Topical cosmetic exposure and systemic absorption from cosmetic use are expected to be low, so e=1 for breastfeeding adults.
- panax ginseng root extract은 아기 피부에 안전한가요?
- Hazard and mechanism scores remain the same (2) because there is animal/in vitro evidence of developmental or endocrine activity for ginsenosides; infant‑specific reproductive/teratogenic data were not identified. Exposure (e) is increased by +1 for baby skin versus adults because infant skin has higher absorption and the CIR data show the ingredient is used in leave‑on and rinse formulations (albeit at low concentrations), so e=2 for babies 0–3 years.
- VeriMom은 panax ginseng root extract을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 panax ginseng root extract을 40/100 (중간 위험)로 평가합니다.
- 임신 중 panax ginseng root extract 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.